cécile vindis
Center for Clinical Investigation 1436, University Hospital Rangueil
Toulouse, France
Review Editor
Cardiovascular and Hematologic Drugs
Type at least 3 characters
722 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
duc duy vo
Biomedical Centre, Uppsala University
Uppsala, Sweden
Review Editor
Technologies and Strategies to Enable Drug Discovery
bingxin wang
Temple University
Philadelphia, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
fang wang
Sun Yat-sen University Cancer Center (SYSUCC)
Guangzhou, China
Review Editor
Anti-Cancer Drugs
jinan wang
University of North Carolina at Chapel Hill
Chapel Hill, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
junjian wang
Sun Yat-sen University
Guangzhou, China
Review Editor
Anti-Cancer Drugs
zhen-zhong wang
Jiangsu Kanion Pharmaceutical Co., Ltd.
Lianyungang, China
Review Editor
Cardiovascular and Hematologic Drugs
karen c. weber
Federal University of Paraíba
João Pessoa, Brazil
Review Editor
Technologies and Strategies to Enable Drug Discovery
pathum weerawarna
School of Medicine, Indiana University Bloomington
Indianapolis, United States
Review Editor
Anti-Cancer Drugs
charles williams
University of Maryland
Baltimore, United States
Review Editor
Cardiovascular and Hematologic Drugs
kelin xia
Nanyang Technological University
Singapore, Singapore
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
hua xiang
China Pharmaceutical University
Nanjing, China
Review Editor
Anti-Cancer Drugs
wei xiao
Jiangsu Kanion Pharmaceutical Co., Ltd.
Lianyungang, China
Review Editor
Cardiovascular and Hematologic Drugs
shunbin xiong
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Anti-Cancer Drugs
huji xu
Tsinghua University
Beijing, China
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
jun xu
Sun Yat-sen University
Guangzhou, China
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery